XRF Scientific (ASX:XRF) EBIT: A$15.35 Mil (TTM As of Dec. 2025)


ASX:XRF XRF Scientific Ltd ASX:XRF
99 GF Score
Price A$1.79
GF Value A$1.65
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is XRF Scientific EBIT?

XRF Scientific ASX:XRF -5.05% 99 EBIT is A$15.35 Mil as of Dec. 2025. GuruFocus rates ASX:XRF with a GF Score™ of 99/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review.

XRF Scientific's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was A$7.54 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was A$15.35 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. XRF Scientific's annualized ROC % for the quarter that ended in Dec. 2025 was 16.50%. XRF Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 45.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. XRF Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 6.25%.

XRF Scientific  (ASX:XRF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

XRF Scientific's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=13.13 * ( 1 - 29.73% )/( (56.209 + 55.599)/ 2 )
=9.226451/55.904
=16.50 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=72.786 - 4.345 - ( 12.232 - max(0, 9.536 - 41.964+12.232))
=56.209

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=70.032 - 2.363 - ( 12.07 - max(0, 5.891 - 39.529+12.07))
=55.599

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

XRF Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=15.072/( ( (11.715 + max(20.899, 0)) + (11.543 + max(22.302, 0)) )/ 2 )
=15.072/( ( 32.614 + 33.845 )/ 2 )
=15.072/33.2295
=45.36 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(10.017 + 18.834 + 0.62) - (4.345 + 0.934 + 3.293)
=20.899

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.964 + 17.851 + 0.64400000000001) - (2.363 + 0.48 + 2.314)
=22.302

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

XRF Scientific's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=15.352/245.667
=6.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XRF Scientific EBIT Related Terms

XRF Scientific EBIT Historical Data

* Premium members only.

The historical data trend for XRF Scientific's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XRF Scientific EBIT Chart

XRF Scientific Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.82 8.26 12.01 13.75 14.85

XRF Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.48 7.27 7.03 7.82 7.54

ASX:XRF vs HON, MMM: EBIT Comparison

For the Conglomerates subindustry, XRF Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XRF Scientific EV-to-EBIT vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, XRF Scientific's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where XRF Scientific's EV-to-EBIT falls into.


ASX:XRF
99GF Score
XRF Scientific Ltd ASX:XRF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XRF Scientific EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$15.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of A$15.35 Mil mean?
XRF Scientific (ASX:XRF) has a EBIT of A$15.35 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on XRF Scientific.
Is XRF Scientific's EBIT too high?
XRF Scientific's current EBIT is A$15.35 Mil. Overall, XRF Scientific has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's EBIT compare to HON and MMM?
XRF Scientific's EBIT of A$15.35 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Conglomerates company?
A good EBIT depends on the Conglomerates industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on XRF Scientific. XRF Scientific's current EBIT is A$15.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.79 — trading 8.2% above its estimated fair value. The current EBIT is A$15.35 Mil. XRF Scientific's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current EBIT is A$15.35 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XRF Scientific (ASX:XRF) Overvalued in 2026?

Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued. The current stock price of A$1.79 is trading 8.2% above its estimated GF Value™ of A$1.65. GuruFocus considers XRF Scientific to be Fairly Valued.

Key valuation signals for ASX:XRF:

  • EBIT: A$15.35 Mil
  • GF Value™: A$1.65 vs. price of A$1.79 (8.2% above fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XRF Scientific Business Description

Address 86 Guthrie Street, Osborne Park, Perth, WA, AUS, 6017
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
99GF Score

Get the complete analysis for ASX:XRF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.79
Price
A$1.65
GF Value